Company | Qnity Electronics, Inc. | Ticker | NYSE: Q |
Earnings Date | August 4, 2026 (BMO) | Prepared | August 3, 2026 |
Reporting Period | Q2 2026 (2QFY-2026, ending June 30, 2026) | Last Earnings | May 12, 2026 (Q1 2026) |
Key Takeaway: Setup leans toward a beat — consensus for Q2 2026 revenue ($1.36B) sits modestly above Q1's $1.315B actual, consistent with management's guided mid-single-digit sequential growth, but the bar is not stretched; the bigger swing factor is whether ICS can sustain its record-margin trajectory and whether Semi restocking tailwinds recur.
Heading into Q2 2026, the setup for Qnity is constructive but not euphoric. Management guided explicitly for mid-single-digit sequential net sales growth, with ICS in the high-single digits and Semi roughly flat — a bar that consensus has essentially matched, leaving limited room for a guidance-driven re-rating but also little risk of a miss if execution holds. The tone from the Q1 call was notably confident: CEO Jon Kemp cited continued strong order books, positive demand signals, and ongoing node transitions and PoR wins as of early Q2, while interim CFO Mike Goss flagged that the second-half guide embeds a prudent view on inflation, implying potential upside if macro conditions improve. Estimate revisions have been modestly positive since the Q1 beat — FY2026 revenue consensus has moved from ~$5.377B to $5.415B and EPS from ~$4.108 to $4.184 — suggesting the Street has absorbed the raise without fully pricing in further upside. The stock, however, has given back roughly 21% since the Q1 earnings date (May 12 close of $168.36 to ~$133.30 as of August 4), meaningfully underperforming both the S&P 500 (+2.6%) and SOXX (−1.6%), which means the stock is entering the print at a compressed multiple with sentiment reset — a setup that historically favors a positive reaction on any in-line or better result. The key wildcard is the ICS margin trajectory: Q1 delivered a record 28.5% ICS EBITDA margin (up 280bps sequentially), and management guided for continued progression toward the mid-to-high 20s — if ICS margins hold or expand further in Q2, it would validate the structural step-up thesis and likely drive the stock; if they compress on incremental investment spending, it is the most likely source of disappointment.
Key Takeaway: Consensus for Q2 2026 represents a moderate, achievable bar — mid-single-digit sequential revenue growth in line with guidance. The bigger swing factor is ICS margin (guided mid-to-high 20s), where any upside vs. the Q1 record 28.5% would be the primary positive catalyst; a miss on EBITDA margin is the key downside risk.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance | Consensus vs. Guidance |
Total Revenue ($M) | $1,315 | $1,170 | $1,364 | +16.6% | Mid-single-digit sequential growth from Q1 ($1,315M) | +0.2% vs. midpoint (~$1,356M implied) |
Revenue — Semiconductor ($M) | $722 | $644 | $722 | +12.1% | Roughly flat sequentially | ~Flat vs. guidance midpoint |
Revenue — ICS ($M) | $593 | $526 | $641 | +21.9% | High-single-digit sequential growth | +0.1% vs. midpoint (~$640M implied) |
Adj. EBITDA ($M) | $411 | $354 | $417 | +17.8% | N/A (FY only) | N/A |
Adj. EBITDA Margin (%) | 31.3% | 30.3% | 30.6% | +30bps YoY | ICS: mid-to-high 20s; Semi: mid-30s | ~In line with blended guidance |
Adj. EPS — Diluted ($) | $1.076 | $0.763 | $1.074 | +40.8% | N/A (FY: $3.80–$4.14) | N/A (FY consensus $4.18 vs. midpoint $3.97, +5.4%) |
Free Cash Flow ($M) | $13 | $223 | $100 | −55.2% | FY: $500M–$600M | FY consensus $479M vs. midpoint $550M, −12.9% |
Sources: Visible Alpha consensus and actuals data. Q2 2026 consensus as of August 3, 2026. Revenue guidance midpoint for Q2 implied from Q1 actual ($1,315M) + mid-single-digit sequential growth (~3–5%). ICS guidance midpoint implied from Q1 actual ($593M) + high-single-digit sequential growth (~8–9%). Semi guidance midpoint implied from Q1 actual ($722M) + roughly flat. FCF Q1 2026 actual is seasonally depressed (elevated CapEx quarter); FY FCF consensus vs. guidance midpoint reflects below-guidance positioning.
Quarter | Reported ($M) | Consensus ($M) | Surprise % | Result |
Q1 2026 | $1,315 | $1,271 | +3.5% | Beat |
Q4 2025 | $1,190 | $1,152 | +3.3% | Beat |
Q3 2025 | $1,276 | $1,185 | +7.7% | Beat |
Q2 2025 | $1,170 | N/A — pre-spin | N/A | N/A |
Q1 2025 | $1,118 | N/A — pre-spin | N/A | N/A |
Q4 2024 | $1,101 | N/A — pre-spin | N/A | N/A |
Q3 2024 | $1,148 | N/A — pre-spin | N/A | N/A |
Q2 2024 | $1,104 | N/A — pre-spin | N/A | N/A |
Quarter | Reported ($) | Consensus ($) | Surprise % | Result |
Q1 2026 | $1.076 | $0.929 | +15.8% | Beat |
Q4 2025 | $0.824 | $0.655 | +25.8% | Beat |
Q3 2025 | $0.839 | $0.613 | +36.9% | Beat |
Q2 2025 | $0.763 | N/A — pre-spin | N/A | N/A |
Q1 2025 | $0.812 | N/A — pre-spin | N/A | N/A |
Q4 2024 | $0.869 | N/A — pre-spin | N/A | N/A |
Q3 2024 | $0.834 | N/A — pre-spin | N/A | N/A |
Q2 2024 | $0.694 | N/A — pre-spin | N/A | N/A |
Pattern: Since becoming a standalone public company (Q3 2025 onward), Qnity has beaten consensus on both revenue and EPS in all three reported quarters, with EPS beats averaging ~26% above consensus — a consistently high bar-setting pattern that reflects conservative guidance and strong execution, but also means the Street has been slow to fully credit the earnings power. Pre-spin consensus data is not available for Q2 2024 through Q2 2025. Source: Visible Alpha consensus and actuals data.
Key Takeaway: Guidance was raised across all metrics at Q1 2026 earnings (May 12) and has not been formally revised since; tone remains confident with a deliberate second-half conservatism on macro/tariff, which management has explicitly flagged as a potential source of upside if conditions improve.
Metric | Initial Guidance (Q1 2026 Earnings, May 12) | Revised Guidance | Current Consensus | Note |
FY2026 Net Sales | $5.225B – $5.375B | — | $5.415B | Consensus sits ~0.7% above guidance midpoint ($5.300B); no post-earnings revision to guidance |
FY2026 Adj. Operating EBITDA | $1.535B – $1.625B | — | $1.631B | Consensus ~0.4% above guidance midpoint ($1.580B); margin expansion thesis intact |
FY2026 Adj. EPS | $3.80 – $4.14 | — | $4.184 | Consensus +5.4% above guidance midpoint ($3.97); Street pricing in modest outperformance |
FY2026 Adj. Free Cash Flow | $500M – $600M | — | $479M | Consensus −12.9% below guidance midpoint ($550M); Street more cautious on FCF given elevated CapEx (~9% of sales in 2026) |
Q2 2026 Net Sales (sequential) | Mid-single-digit sequential growth from Q1 ($1,315M) | — | $1,364M (+3.7% seq.) | Consensus in line with guidance; Semi roughly flat, ICS high-single-digit sequential growth |
Q2 2026 Semi Margin | Mid-30s% | — | ~30.6% blended (VA) | Segment-level margin guidance unchanged; Semi mid-30s, ICS mid-to-high 20s |
FY2026 MSI Wafer Start Growth | Mid-to-high single digits (upgraded from mid-single digits at Q1) | — | N/A — not in VA | CEO noted “room to do even better” as year progresses; key leading indicator for revenue outperformance |
Note: The only post-earnings corporate event was the July 1, 2026 term loan repricing (8-K), which reduced the interest rate margin by 25bps on $2.338B of term loans — a modest positive for interest expense but not a guidance revision. No formal guidance update has been issued since the Q1 2026 earnings call on May 12, 2026. Sources: Q1 2026 Earnings Release and Transcript (May 12, 2026); Visible Alpha consensus data.
Key Takeaway: Estimates have drifted modestly higher since the Q1 2026 print — FY2026 revenue and EPS consensus are now slightly above the guidance midpoint, suggesting the Street has absorbed the raise and is beginning to price in modest outperformance. The gap is not large enough to represent a stretched bar, but it does mean the stock needs a clean beat-and-raise to re-rate from current depressed levels.
KPI (Period) | Estimate (5/17/26, +5 Days Post Q1) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Total Revenue — Q2 2026 | $1,361M | $1,364M | +0.2% | Mid-SD seq. growth (~$1,356M midpoint) | Unchanged | — | +0.6% |
Total Revenue — FY2026 | $5,377M | $5,415M | +0.7% | $5,225M – $5,375M | Unchanged | — | +2.2% vs. midpoint |
Total Revenue — FY2027 | $5,876M | $5,960M | +1.4% | N/A | N/A | — | N/A |
Adj. EPS — Q2 2026 | $1.061 | $1.074 | +1.2% | N/A (FY: $3.80–$4.14) | Unchanged | — | N/A |
Adj. EPS — FY2026 | $4.108 | $4.184 | +1.9% | $3.80 – $4.14 | Unchanged | — | +5.4% vs. midpoint |
Adj. EPS — FY2027 | $4.801 | $4.943 | +3.0% | N/A | N/A | — | N/A |
Adj. EBITDA — FY2026 | $1,612M | $1,631M | +1.2% | $1,535M – $1,625M | Unchanged | — | +0.4% vs. midpoint |
Estimates are tracking guidance closely and drifting modestly higher, consistent with the Street gradually pricing in the company's track record of conservative guidance. The most notable divergence is on FCF, where consensus ($479M) sits well below the guidance midpoint ($550M), reflecting uncertainty around the timing of CapEx normalization. FY2027 EPS has moved up +3.0% since the Q1 print, suggesting growing confidence in the medium-term earnings trajectory. Source: Visible Alpha consensus and actuals data; as-of date May 17, 2026 (5 trading days post Q1 earnings).
Key Takeaway: Q has dramatically underperformed since Q1 earnings — down ~21% vs. S&P 500 +2.6% and SOXX −1.6% — driven by multiple compression and sector rotation rather than estimate cuts, which means the stock enters Q2 earnings with sentiment reset and a lower bar for a positive reaction.
Q vs. SOXX vs. S&P 500 — Indexed to 100 at May 12, 2026 (Q1 2026 Earnings Date). Source: Yahoo Finance / Stock Price Data.
Since the Q1 2026 earnings date (May 12, 2026), Q has declined from $168.36 to $133.30 as of August 4, 2026, a loss of −20.8% on an absolute basis. This compares to the S&P 500 (SPY) gaining +2.6% and the SOXX semiconductor ETF declining −1.6% over the same period. The underperformance is striking: Q has lagged the SOXX by ~19 percentage points and the S&P 500 by ~23 percentage points since its last earnings beat. The stock peaked at $175.64 on June 22 before a sustained selloff through late July, reaching a trough near $123.39 on July 29. The selloff appears driven by multiple compression and sector rotation rather than fundamental deterioration — FY2026 consensus estimates have actually moved modestly higher since the Q1 print. Key events during the period include the Wolfe Research Materials of the Future Conference (June 12–13), where management reinforced the strategic narrative, and the July 1 term loan repricing (a modest positive). The stock's sharp underperformance relative to both the market and its semiconductor peers sets up a potentially asymmetric reaction to a clean Q2 beat-and-raise, as the valuation has de-rated meaningfully from post-Q1 levels. Sector ETF used: SOXX (iShares Semiconductor ETF), appropriate for Q's semiconductor materials and advanced packaging sub-sector exposure.
Key Takeaway: Peer commentary from the last 60 days is uniformly bullish on the demand environment that drives Qnity's business — wafer starts accelerating, advanced packaging growing 50–70%+, HBM demand intensifying, and fab utilization at or near 100% — all of which are direct read-throughs to Q's consumables-heavy revenue model. The read-through from KLAC, LRCX, AMAT, and TSM is among the most constructive in recent memory.
Note: Only commentary from the last 60 days (since ~June 4, 2026) that speaks to the current reporting quarter (Q2 2026 calendar period) or the forward demand environment is included below. Prior-quarter result commentary is excluded per the user's instruction.
Read-Through Summary: The collective message from AMAT, KLAC, LRCX, TSM, and TER is unambiguously positive for Q's Q2 2026 setup: wafer starts are at record growth rates, advanced packaging is growing 50–70%+, HBM demand is intensifying, fab utilization is at or near 100%, and the H2 2026 demand environment is accelerating. The only nuance is mixed mature node demand in commodity segments (consumer electronics), which is partially offset by Q's stated exposure to premium devices and the normal seasonal increase in consumer electronics that management guided for in Q2. On balance, peer commentary represents one of the most constructive read-through environments for Q's business model in recent quarters.
Key Takeaway: The most important development since Q1 earnings is the term loan repricing (July 1), which reduces interest costs and signals improving financial flexibility; the Wolfe Research conference (June 12–13) reinforced the strategic narrative around the 'shrink to stack' transition and ICS re-rating thesis. No negative developments have emerged.
Key Takeaway: No open-market buys or discretionary sells by executives or directors since Q1 earnings. All transactions are routine director equity award grants (code A) or a single tax-withholding share surrender (code F) — nothing that signals insider conviction or concern about the upcoming print.
Name | Title | Transaction Type | Shares | Date | Note |
Fortebuono, Kathleen M. | Chief People Officer | Share Surrender (Tax Withholding) | 418 shares | Jun 12, 2026 | Code F — mandatory tax withholding on vesting; not a discretionary sale |
Sterin, Steven | Director | Open Market Sale | 400 shares | Jun 5, 2026 | Code S — small discretionary sale by director; no 10b5-1 plan disclosed; modest size, not flagged as significant |
Curtin, Terrence R. | Director | Equity Award Grant | 208 shares | May 29, 2026 | Code A — routine director equity compensation grant; not a market purchase |
Green, Byron | Director | Equity Award Grant | 208 shares | May 29, 2026 | Code A — routine director equity compensation grant |
Banerji, Shumeet | Director | Equity Award Grant | 1,278 shares | May 21, 2026 | Code A — routine annual director equity grant (same amount for all directors on same date) |
Blinn, Mark A. | Director | Equity Award Grant | 1,278 shares | May 21, 2026 | Code A — routine annual director equity grant |
Curtin, Terrence R. | Director | Equity Award Grant | 1,278 shares | May 21, 2026 | Code A — routine annual director equity grant |
De Bondt, Karin | Director | Equity Award Grant | 1,278 shares | May 21, 2026 | Code A — routine annual director equity grant |
Green, Byron | Director | Equity Award Grant | 1,278 shares | May 21, 2026 | Code A — routine annual director equity grant |
Johnson, Kristina M. | Director | Equity Award Grant | 1,278 shares | May 21, 2026 | Code A — routine annual director equity grant |
Noonan, Anne P. | Director | Equity Award Grant | 1,278 shares | May 21, 2026 | Code A — routine annual director equity grant |
Paik, Yi Hyon | Director | Equity Award Grant | 1,278 shares | May 21, 2026 | Code A — routine annual director equity grant |
Sterin, Steven | Director | Equity Award Grant | 1,278 shares | May 21, 2026 | Code A — routine annual director equity grant |
Assessment: The insider transaction picture is benign. The May 21 grants are routine annual director equity compensation awards (all directors received identical 1,278-share grants on the same date), which carry no informational signal. The May 29 grants to Curtin and Green are smaller supplemental awards. The June 12 share surrender by CPO Fortebuono is a mandatory tax withholding on vesting — not a discretionary sale. The only transaction that could be considered a discretionary sale is Director Sterin's 400-share open-market sale on June 5, which is small in size relative to his 12,195-share post-transaction holding and does not represent a meaningful signal. Notably, there are no open-market buys by any executive or director since the Q1 earnings date, and no 10b5-1 plan initiations disclosed. The absence of insider buying despite the ~21% stock decline since Q1 earnings is worth noting, though it is not unusual for a company this early in its post-spin lifecycle. Source: SEC Form 4 filings, Insider Transaction Data.